Michael J Duffy Selected Research

APTO-253

3/2021

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael J Duffy Research Topics

Disease

65	Breast Neoplasms (Breast Cancer) 07/2022 - 01/2002
65	Neoplasms (Cancer) 07/2022 - 01/2002
12	Neoplasm Metastasis (Metastasis) 10/2020 - 01/2002
10	Colorectal Neoplasms (Colorectal Cancer) 01/2015 - 09/2004
9	Triple Negative Breast Neoplasms 07/2022 - 12/2012
9	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 09/2004
9	Ovarian Neoplasms (Ovarian Cancer) 12/2018 - 09/2004
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 04/2011
5	Fibroadenoma 03/2007 - 02/2003
3	Circulating Neoplastic Cells 10/2018 - 01/2015
3	Lymphatic Metastasis 10/2010 - 07/2005
3	Carcinoma (Carcinomatosis) 04/2007 - 02/2003
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 03/2021
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2021 - 01/2021
2	Ovarian Epithelial Carcinoma 01/2016 - 01/2015
2	Neuroblastoma 01/2015 - 03/2010
2	Liver Neoplasms (Liver Cancer) 01/2015 - 03/2010
2	Nonseminomatous germ cell tumor 01/2013 - 05/2007
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2010 - 08/2005
2	Stomach Neoplasms (Stomach Cancer) 06/2010 - 08/2005
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 12/2008 - 11/2008
2	Noninfiltrating Intraductal Carcinoma (DCIS) 03/2006 - 08/2005
1	Hypercholesterolemia 07/2022
1	Microsatellite Instability 10/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Adenocarcinoma 01/2018

Drug/Important Bio-Agent (IBA)

38	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2002
21	Proteins (Proteins, Gene)FDA Link 07/2022 - 02/2003
14	Tumor Biomarkers (Tumor Markers)IBA 01/2019 - 11/2005
12	Estrogen ReceptorsIBA 01/2022 - 03/2005
12	Trastuzumab (Herceptin)FDA Link 01/2015 - 09/2004
11	Hormones (Hormone)IBA 01/2015 - 01/2002
10	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 08/2014 - 01/2002
9	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2005
9	Messenger RNA (mRNA)IBA 01/2021 - 02/2003
8	Progesterone Receptors (Progesterone Receptor)IBA 10/2016 - 03/2005
8	Plasminogen Activators (Plasminogen Activator)IBA 08/2014 - 08/2002
8	Plasminogen Activator Inhibitor 1IBA 08/2014 - 01/2002
7	Pharmaceutical PreparationsIBA 01/2021 - 02/2007
7	Carcinoembryonic AntigenIBA 01/2018 - 09/2004
6	Tyrosine Kinase InhibitorsIBA 01/2022 - 04/2011
6	Prostate-Specific Antigen (Semenogelase)IBA 01/2020 - 09/2004
6	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 02/2003
4	eprenetapoptIBA 01/2021 - 01/2017
4	ErbB Receptors (EGF Receptor)IBA 01/2018 - 02/2009
4	human ERBB2 proteinIBA 10/2013 - 11/2008
4	Estrogens (Estrogen)FDA Link 04/2011 - 11/2005
4	SurvivinIBA 11/2010 - 04/2007
3	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2018
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018 - 04/2011
3	Gefitinib (Iressa)FDA Link 01/2018 - 04/2011
3	AntibodiesIBA 10/2013 - 01/2013
3	Cetuximab (Erbitux)FDA Link 10/2013 - 04/2011
3	Panitumumab (Vectibix)FDA Link 10/2013 - 04/2011
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 06/2010 - 11/2008
3	ADAM17 ProteinIBA 05/2009 - 04/2007
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2008 - 09/2004
2	Circulating Tumor DNAIBA 01/2021 - 05/2018
2	Phosphotransferases (Kinase)IBA 10/2020 - 04/2019
2	pembrolizumabIBA 10/2019 - 01/2018
2	Cell-Free Nucleic AcidsIBA 10/2018 - 10/2013
2	squamous cell carcinoma-related antigenIBA 01/2018 - 06/2010
2	Calcitriol (Calcijex)FDA LinkGeneric 04/2017 - 01/2017
2	Vitamin D FDA LinkGeneric 04/2017 - 01/2017
2	inecalcitolIBA 04/2017 - 01/2017
2	AcidsIBA 01/2015 - 03/2010
2	Homovanillic AcidIBA 01/2015 - 03/2010
2	Lapatinib (GW572016)FDA Link 01/2015 - 06/2010
2	Complement System Proteins (Complement)IBA 01/2014 - 07/2011
2	Protein Isoforms (Isoforms)IBA 07/2011 - 09/2005
2	LigandsIBA 06/2011 - 02/2009
2	Indicators and Reagents (Reagents)IBA 11/2010 - 05/2008
2	Tamoxifen FDA LinkGeneric 11/2010 - 05/2009
2	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 12/2008 - 11/2008
2	Cyclin EIBA 04/2007 - 11/2006
2	Mammaglobin AIBA 04/2005 - 08/2002
2	Plasminogen InactivatorsIBA 09/2004 - 08/2002
2	Serine Proteases (Serine Protease)IBA 08/2002 - 04/2002
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2022
1	AlpelisibIBA 01/2022
1	Fulvestrant (Faslodex)FDA Link 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	ParaffinIBA 01/2022
1	RG7388IBA 01/2022
1	APTO-253IBA 03/2021
1	ON 01910IBA 01/2021
1	MYCMI-6IBA 01/2021
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 10/2020
1	src-Family KinasesIBA 10/2020
1	Immune Checkpoint InhibitorsIBA 10/2019
1	B7-H1 AntigenIBA 10/2019
1	Dasatinib (BMS 354825)FDA Link 04/2019
1	2,2- bis(hydroxymethyl)- 1- azabicyclo(2,2,2,)octan- 3- oneIBA 07/2018
1	osimertinibIBA 01/2018
1	AfatinibIBA 01/2018

Therapy/Procedure

39	Therapeutics 01/2022 - 09/2004
5	Adjuvant Chemotherapy 01/2017 - 08/2002
4	Drug Therapy (Chemotherapy) 10/2016 - 09/2006
2	Immunotherapy 01/2022 - 10/2019